New research suggests that heart health metrics are improving among older adults with obesity, but experts warn that the findings should not be taken as evidence that excess weight has become harmless.
Study shows declines in blood pressure and cholesterol for older obese adults
The analysis drew on more than a million individuals from national surveys in seven high‑income countries—South Korea, Japan, Thailand, Taiwan, England, Finland and the United States—spanning the period from 1990 to 2024. Researchers compared systolic blood pressure and non‑HDL cholesterol levels across body‑mass‑index (BMI) categories and found that people aged 40 and older who were overweight or obese experienced sharper declines in these risk factors than their normal‑weight peers.
Among participants aged 60 to 79, the gap narrowed further. In several of the surveyed nations, older obese adults reported systolic blood pressure and cholesterol readings that were comparable to, or sometimes better than, those of people with a normal BMI. The authors attribute these trends to the growing use of antihypertensive and lipid‑lowering medicines over the past three decades.
By contrast, the data showed a pronounced metabolic gap in the younger cohort. Adults under 40 who were overweight or obese consistently had higher blood pressure and cholesterol levels than their normal‑weight counterparts, indicating that the benefits observed in older age groups have not yet extended to younger populations.
Experts caution against over‑interpreting the results
Independent commentators stress that the study’s observational design cannot establish causality. Dr. Marie Spreckley of the University of Cambridge highlighted the research’s scale and the use of objectively measured health indicators, but she warned that changes in diet, smoking habits, physical activity, and evolving clinical guidelines could also explain the observed improvements.
Related: How to Improve Hospital Security in the Face of Modern Technology
“Importantly, these findings should not be interpreted as showing that obesity has become benign,” she said. The analysis focused on risk factors rather than actual cardiovascular events or mortality, so it remains unclear whether the reductions in blood pressure and non‑HDL cholesterol translate into fewer heart attacks or deaths.
In the middle of the discussion, it’s worth noting that similar trends have been seen in earlier European health surveys, where widespread statin use coincided with modest declines in population‑level cholesterol. Those historic patterns suggest that medication can shift averages, yet they do not automatically resolve the underlying issues linked to excess weight.
Nevertheless, researchers argue that reliance on pharmacologic treatment alone is insufficient. Naveed Sattar of the University of Glasgow warned that focusing only on downstream risk factors may extend life expectancy while leaving many individuals living longer with obesity‑related chronic conditions.
He advocated for a dual approach that combines obesity prevention and treatment with optimal cardiovascular risk management.
The American College of Cardiology and American Heart Association recently updated their dyslipidemia guidelines, stressing lifestyle changes—particularly Mediterranean, DASH, and vegetarian diets—as first‑line therapy for high LDL cholesterol.
This aligns with the study’s implication that medication, while valuable, should be paired with dietary and behavioral interventions.
Overall, the findings illustrate a complex picture: older obese adults in high‑income countries are seeing better blood‑pressure and cholesterol numbers, likely due in part to increased medication use.
Yet the persistence of other risk markers and the lack of data on actual cardiovascular outcomes mean that the health community must remain cautious.
As the prevalence of obesity continues to rise, the study reinforces the need for strategies that address both weight management and cardiometabolic risk, rather than relying on medication alone to curb the growing burden of chronic disease.
